INCY EBITDA | INCYTE CORPORATION

INCYTE CORPORATION (INCY) EBITDA

2026-03-31: Basis Reported; EBITDA $324.92M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $359.84M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $467.54M*; Operating income $443.52M; Depreciation and amortization $24.02M*.
2025-06-30: Basis Reported; EBITDA $553.23M*; Operating income $530.31M; Depreciation and amortization $22.92M*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-03-31	Reported	$324.92M	(m)	(m)	(m)	25.53%	(m)	$369.35M	(m)	$515.90M	$328.09M	$40.27M
2025-12-31	Reported	$359.84M	(m)	(m)	(m)	23.88%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$467.54M*	$443.52M	$24.02M*	$1.37B	34.23%*	(m)	$559.39M*	(m)	$506.58M	$329.08M	$58.14M
2025-06-30	Reported	$553.23M*	$530.31M	$22.92M*	$1.22B	45.51%*	(m)	$44.74M*	(m)	$494.92M	$331.02M	$153.01M
2025-03-31	Reported	$227.53M	(m)	(m)	(m)	21.61%	(m)	$266.07M	(m)	$437.28M	$325.69M	$75.99M
2024-12-31	Reported	$324.25M	(m)	(m)	(m)	27.51%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$168.60M*	$146.09M	$22.52M*	$1.14B	14.82%*	(m)	$310.87M*	(m)	$573.17M	$309.21M	$50.07M
2024-06-30	Reported	-$456.08M*	-$478.13M	$22.05M*	$1.04B	-43.70%*	(m)	-$575.56M*	(m)	$1.14B	$305.98M	$54.82M
2024-03-31	Reported	$113.85M	(m)	(m)	(m)	12.92%	(m)	$218.81M	(m)	$429.26M	$300.26M	$66.61M
2023-12-31	Reported	$209.03M	(m)	(m)	(m)	20.63%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$236.09M*	$214.71M	$21.39M*	$919.02M	25.69%*	(m)	$147.84M*	(m)	$375.71M	$267.89M	$62.53M
2023-06-30	Reported	$214.08M*	$193.78M	$20.30M*	$954.61M	22.43%*	(m)	$306.53M*	(m)	$400.75M	$283.93M	$74.06M
2023-03-31	Reported	$43.98M	(m)	(m)	(m)	5.44%	(m)	-$105.60M	(m)	$406.64M	$315.61M	$30.15M
2022-12-31	Reported	$88.31M	(m)	(m)	(m)	9.53%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$155.07M*	$138.38M	$16.69M*	$823.30M	18.83%*	(m)	$296.38M*	(m)	$384.01M	$266.46M	$35.81M
2022-06-30	Reported	$270.94M*	$254.43M	$16.51M*	$911.40M	29.73%*	(m)	$174.16M*	(m)	$347.20M	$253.28M	$67.95M
2022-03-31	Reported	$132.98M	(m)	(m)	(m)	18.14%	(m)	$215.74M	(m)	$353.37M	$209.58M	$32.54M
2021-12-31	Reported	$125.59M	(m)	(m)	(m)	14.56%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$250.10M*	$235.41M	$14.69M*	$812.99M	30.76%*	(m)	$255.10M*	(m)	$334.94M	$190.70M	$27.73M
2021-06-30	Reported	$155.29M*	$140.84M	$14.46M*	$705.71M	22.01%*	(m)	$172.94M*	(m)	$343.51M	$168.86M	$22.18M
2021-03-31	Reported	$112.64M	(m)	(m)	(m)	18.63%	(m)	$206.09M	(m)	$306.90M	$153.79M	$15.79M
2020-12-31	Reported	$177.4M	(m)	(m)	(m)	22.47%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$18.27M*	$5.33M	$12.95M*	$620.64M	2.94%*	(m)	$182.12M*	(m)	$438.11M	$120.79M	$11.70M
2020-06-30	Reported	$243.37M*	$230.77M	$12.59M*	$688.04M	35.37%*	(m)	$269.38M*	(m)	$286.60M	$118.00M	$16.97M
2020-03-31	Reported	-$650.91M	(m)	(m)	(m)	-114.49%	(m)	-$683.42M	(m)	$1.09B	$111.15M	$16.57M
2019-12-31	Reported	$108.35M	(m)	(m)	(m)	18.70%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$148.18M*	$134.32M	$13.86M*	$551.58M	26.86%*	(m)	$270.42M*	(m)	$281.34M	$102.61M	$19.75M
2019-06-30	Reported	$112.05M*	$98.61M	$13.44M*	$529.93M	21.14%*	(m)	$152.96M*	(m)	$289.36M	$105.94M	$3.35M
2019-03-31	Reported	$87.96M	(m)	(m)	(m)	17.67%	(m)	$155.66M	(m)	$270.55M	$123.98M	$1.78M
2018-12-31	Reported	$96.2M	(m)	(m)	(m)	18.21%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	$44.94M*	$31.12M	$13.82M*	$449.68M	9.99%*	(m)	$199.15M*	(m)	$292.53M	$96.52M	$1.80M
2018-06-30	Reported	$96.74M*	$83.24M	$13.50M*	$521.52M	18.55%*	(m)	$32.40M*	(m)	$298.09M	$108.03M	$1.61M
2018-03-31	Reported	-$53.69M	(m)	(m)	(m)	-14.04%	(m)	$20.84M	(m)	$303.10M	$121.50M	$786.00K
2017-12-31	Reported	-$119.56M	(m)	(m)	(m)	-26.92%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$26.96M*	$15.02M	$11.94M*	$381.53M	7.07%*	(m)	$53.12M*	(m)	$269.56M	$91.27M	$7.30M
2017-06-30	Reported	$19.61M*	$7.26M	$12.35M*	$326.44M	6.01%*	(m)	$116.79M*	(m)	$201.79M	$90.07M	$3.10M
2017-03-31	Reported	-$118.22M	(m)	(m)	(m)	-30.78%	(m)	-$173.64M	(m)	$407.92M	$87.23M	-$10.90M
2016-12-31	Reported	$59.65M	(m)	(m)	(m)	18.27%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$39.24M*	$22.29M	$16.95M*	(m)	(m)	(m)	$95.27M*	(m)	$143.18M	$75.78M	$1.43M
2016-06-30	Reported	$57.44M*	$44.59M	$12.85M*	(m)	(m)	(m)	(m)	(m)	$120.27M	$66.79M	$785.00K
2016-03-31	Reported	$47.1M	(m)	(m)	(m)	17.88%	(m)	(m)	(m)	$156.82M	$64.60M	$400.00K
2015-12-31	Reported	$75.68M	(m)	(m)	(m)	31.03%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$11.08M*	-$101.00K	$11.18M*	(m)	(m)	(m)	(m)	(m)	$132.07M	$47.60M	$9.00K
2015-06-30	Reported	$3.87M*	-$7.39M	$11.27M*	(m)	(m)	(m)	(m)	(m)	$112.44M	$51.68M	$136.00K
2015-03-31	Reported	$4.9M	(m)	(m)	(m)	3.08%	(m)	(m)	(m)	$118.36M	$44.87M	$367.00K
2014-12-31	Reported	-$13.4M	(m)	(m)	(m)	-10.81%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$79.81M*	$69.94M	$9.87M*	(m)	(m)	(m)	(m)	(m)	$88.54M	$39.45M	$72.00K
2014-06-30	Reported	-$16.49M*	-$26.19M	$9.70M*	(m)	(m)	(m)	(m)	(m)	$84.68M	$40.90M	$70.00K
2014-03-31	Reported	-$13.31M	(m)	(m)	(m)	-14.83%	(m)	(m)	(m)	$75.58M	$36.97M	$49.00K
2013-12-31	Reported	-$7.29M	(m)	(m)	(m)	-7.51%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$8.62M*	-$13.18M	$4.57M*	(m)	(m)	(m)	(m)	(m)	$71.70M	$26.45M	$49.00K
2013-06-30	Reported	$25.37M*	$17.32M	$8.05M*	(m)	(m)	(m)	(m)	(m)	$60.95M	$23.25M	$71.00K
2013-03-31	Reported	$3.64M	(m)	(m)	(m)	5.12%	(m)	(m)	(m)	$52.76M	$22.26M	$43.00K
2012-12-31	Reported	$38.02M	(m)	(m)	(m)	33.40%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$2.56M*	-$10.14M	$7.58M*	(m)	(m)	(m)	(m)	(m)	$50.08M	$20.52M	$26.00K
2012-06-30	Reported	$22.62M*	$15.22M	$7.40M*	(m)	(m)	(m)	(m)	(m)	$51.59M	$19.72M	$67.00K
2012-03-31	Reported	-$26.95M	(m)	(m)	(m)	-74.50%	(m)	(m)	(m)	$48.96M	$21.40M	(m)
2011-12-31	Reported	-$37.1M	(m)	(m)	(m)	-128.41%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$35.23M*	-$42.10M	$6.87M*	(m)	(m)	(m)	(m)	(m)	$44.60M	$14.28M	(m)
2011-06-30	Reported	-$34.47M*	-$41.11M	$6.65M*	(m)	(m)	(m)	-$30.74M*	(m)	$46.05M	$11.86M	(m)
2011-03-31	Reported	-$9.4M	(m)	(m)	(m)	-29.38%	(m)	-$44.22M	(m)	$36.28M	$10.82M	(m)
2010-12-31	Reported	$49.14M	(m)	(m)	(m)	57.22%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$16.68M*	-$22.06M	$5.38M*	(m)	(m)	(m)	(m)	(m)	$30.61M	$8.46M	-$658.00K
2010-06-30	Reported	$19.51M*	$13.62M	$5.88M*	(m)	(m)	(m)	-$2.77M*	(m)	$28.88M	$7.49M	$331.00K
2010-03-31	Reported	-$13.43M	(m)	(m)	(m)	-77.71%	(m)	$102.82M	(m)	$31.44M	$5.79M	$327.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$1.61B	(m)	(m)	(m)	31.28%	(m)	$1.41B	(m)	$2.05B	$1.38B	$377.80M
2024-12-31	Reported	$150.61M	(m)	(m)	(m)	3.55%	(m)	$335.34M	(m)	$2.61B	$1.24B	$284.01M
2023-12-31	Reported	$703.19M	(m)	(m)	(m)	19.03%	(m)	$496.49M	(m)	$1.63B	$1.16B	$236.62M
2022-12-31	Reported	$647.3M	(m)	(m)	(m)	19.07%	(m)	$969.94M	(m)	$1.59B	$1.00B	$188.46M
2021-12-31	Reported	$643.62M	(m)	(m)	(m)	21.55%	(m)	$749.49M	(m)	$1.46B	$739.56M	-$378.14M
2020-12-31	Reported	-$211.87M	(m)	(m)	(m)	-7.94%	(m)	-$124.60M	(m)	$2.22B	$516.92M	$63.48M
2019-12-31	Reported	$456.54M	(m)	(m)	(m)	21.15%	(m)	$710.66M	(m)	$1.15B	$468.71M	$39.88M
2018-12-31	Reported	$184.19M	(m)	(m)	(m)	9.79%	(m)	$336.23M	(m)	$1.20B	$434.41M	$5.85M
2017-12-31	Reported	-$191.21M	(m)	(m)	(m)	-12.45%	(m)	-$92.99M	(m)	$1.33B	$366.29M	$852.00K
2016-12-31	Reported	$203.42M	(m)	(m)	(m)	18.40%	(m)	$304.76M	(m)	$581.86M	$303.25M	$3.18M
2015-12-31	Reported	$95.53M	(m)	(m)	(m)	12.67%	(m)	$89.41M	(m)	$479.51M	$196.61M	$1.02M
2014-12-31	Reported	$36.61M	(m)	(m)	(m)	7.16%	(m)	(m)	(m)	$347.52M	$165.77M	-$66.00K
2013-12-31	Reported	$13.11M	(m)	(m)	(m)	3.69%	(m)	(m)	(m)	$260.44M	$109.98M	$299.00K
2012-12-31	Reported	$31.13M	(m)	(m)	(m)	10.48%	(m)	(m)	(m)	$210.39M	$85.36M	$174.00K
2011-12-31	Reported	-$116.19M	(m)	(m)	(m)	-123.01%	(m)	(m)	(m)	$178.71M	$58.22M	(m)
2010-12-31	Reported	$38.53M	(m)	(m)	(m)	22.68%	(m)	(m)	(m)	$123.88M	$32.33M	(m)
2009-12-31	Reported	-$123.08M	(m)	(m)	(m)	-1328.42%	(m)	(m)	(m)	$119.44M	$27.58M	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Medpace Holdings, Inc. (MEDP)	United States	$17.316B	30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)	United States	$14.060B	-43.97
IQVIA HOLDINGS INC. (IQV)	United States	$45.926B	20.54
Absci Corp (ABSI)	United States	$1.775B	-14.92
OmniAb, Inc. (OABI)	United States	$0.698B	-8.05
NRC HEALTH (NRC)	United States	$0.450B	42.50
MAXCYTE, INC. (MXCT)	United States	$0.124B	-3.68
bioAffinity Technologies, Inc. (BIAF)	United States	$0.063B
OneMedNet Corp (ONMD)		$0.042B
iSpecimen Inc. (ISPC)	United States	$0.003B